Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D007964:Leukocytosis / Q000139:chemically induced; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D012293:Rifampin / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D012737:Sex Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin